Alpha Calm Soft Capsule 0.5 Micrograms (Alfacalcidol)

Adult dose

Chronic renal failure and osteoporosis: administer 0.5 to 1 µg of Alfacalcidol orally once a day. Hypoparathyroidism and other diseases due to vitamin D metabolism disorders: administer 1 to 4 µg of this medication orally once a day.

Child dose

Osteoporosis: administer 0.01 to 0.03 µg per kg of body weight orally once a day. Other conditions: administer 0.05 to 0.1 µg per kg of body weight orally once a day.

This medication should not be taken by patients with hypercalcemia, hyperphosphatemia, or hypermagnesemia, or by patients with a certain level of calcium and phosphate product in their blood, or by those with alkalosis. Furthermore, individuals who exhibit symptoms of vitamin D toxicity or are allergic to this medication or its components should avoid it. During the course of this medication, it is advisable to avoid taking drugs containing magnesium, vitamin D and its derivatives, calcium-containing drugs, or certain diuretics. Nursing women should avoid this medication as its safety has not been established, and if it must be taken, it is recommended to stop breastfeeding. Women who are pregnant or may become pregnant should take it cautiously after consulting a doctor, due to the risk of harm to the fetus. Children, the elderly, patients on specific medications, and those with kidney stones or sarcoidosis should consult with a professional before taking this medication. While taking this medication, various symptoms related to hypercalcemia may appear, so if abnormal symptoms occur, the medication should be discontinued immediately and consultation should be sought. Serum calcium levels and kidney function should be checked regularly, and if abnormalities are found, appropriate measures must be taken. It is important to adhere to the prescribed dosage, avoid overdose, and follow instructions regarding calcium intake. In case of overdose, discontinue use immediately and seek appropriate treatment; if necessary, emergency measures such as inducing vomiting or gastric lavage may be implemented. This medication should be stored out of reach of children, away from direct sunlight, and in a cool, dry place. Additionally, to maintain quality, it is advisable not to transfer it to another container.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, peeling skin, pain in the oral/eye mucosa, shortness of breath or difficulty breathing, asthma attack, cough with fever and respiratory distress, yellowing of the skin or eyes (jaundice), severe lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urine

Mild side effects

• Loss of appetite
• nausea
• vomiting
• diarrhea
• constipation
• stomach pain
• abdominal discomfort
• bloating
• indigestion
• thirst

This medication may be sensitive to light, so it should be stored in a light-blocking container. It is also recommended that the medication be stored at room temperature between 1 to 30 degrees Celsius. Storing it this way will maintain its effectiveness and allow for safe use.

Appearance

Pink oval soft capsule containing a colorless transparent or light yellow oily solution

Package unit

30 capsules/box [(10 capsules/PTP) X 3], 60 capsules/box [(10 capsules/PTP) X 6], 90 capsules/box [(10 capsules/PTP) X 9]